Beyond BMI: Why Metabolic Health May Be a Better Measure of Your Health

By Katie Sorensen, NP-C | Weight Loss NP

For decades, BMI has been one of the main numbers used to decide whether someone is at a “healthy weight.”

But BMI has serious limitations. It’s pretty terrible, actually.

It does not directly measure genetically inherited stature variants, body fat, muscle mass, visceral fat, insulin resistance, blood pressure, cholesterol, blood sugar, or how excess weight is actually affecting someone’s health.

Two people with the exact same BMI can have very different metabolic health.

This is the main reason we, at Weight Loss NP, and obesity medicine as a specialty, is increasingly looking beyond BMI and toward a more complete picture of metabolic health.

For patients seeking medical weight loss in Denver, Arvada, Colorado, Utah, or Florida, this shift can lead to a much more useful conversation than simply asking, “What number is on the scale?”

Why BMI Does Not Tell the Whole Story

BMI is calculated using height and weight alone. It is inexpensive, simple, and useful as a basic screening tool.

But it is still only a screening tool.

The National Institute of Diabetes and Digestive and Kidney Diseases notes that BMI does not directly measure body fat and may not accurately reflect health risk in some people, including muscular adults, older adults, and people who carry more fat around the abdomen.

This means someone can have:

• A “normal” BMI and significant visceral fat or insulin resistance
• A higher BMI with substantial muscle mass and relatively favorable metabolic markers
• Weight-related health problems that deserve treatment even if their BMI does not seem especially high

That is why BMI alone should not be the entire conversation.

Obesity Medicine Is Moving Beyond BMI

This is not simply a wellness trend.

A major Lancet Diabetes & Endocrinology Commission proposed a new framework for diagnosing obesity that goes beyond BMI alone. The commission recommended assessing excess body fat using measures such as waist circumference or other body composition measures and then evaluating whether that excess adiposity is causing organ dysfunction or limitations in daily life.

The framework distinguishes between preclinical obesity and clinical obesity, with treatment decisions based more heavily on actual health impact.

Instead of evaluating

“What is someone’s BMI” as the main clinical decision point…

We can start evaluating:

“How is your weight affecting your health?”

A New 2026 Guideline Reinforces the Metabolic Health Approach

The movement toward more comprehensive assessment has continued.

The new 2026 cardiovascular-kidney-metabolic health guideline from the American Heart Association, American College of Cardiology, American Diabetes Association, and American Society of Nephrology emphasizes the interconnected nature of obesity, diabetes, kidney disease, and cardiovascular disease.

Importantly, the guideline recommends assessing both BMI and waist circumference when evaluating risk related to excess body fat.

That reflects something we see clinically all the time: where fat is stored and what it is doing metabolically can matter just as much as total body weight.

What Should We Look at Besides BMI?

When I am thinking about someone’s metabolic health, I am much more interested in the full picture.

That may include:

Waist Circumference and Abdominal Fat

Visceral fat, the fat stored around the abdominal organs, is particularly associated with insulin resistance and cardiovascular risk.

Blood Sugar and A1c

These help identify prediabetes, diabetes, and worsening glucose regulation. How our body uses food as energy is essential in cells functioning properly and avoiding disease.

Insulin Resistance

Blood sugar may remain technically “normal” while the body is producing increasingly high levels of insulin to keep it there. Insulin creeping up is a much earlier signal of a metabolic issue.

Cholesterol and Triglycerides

Elevated triglycerides, low HDL cholesterol, and other lipid abnormalities are be important clues about metabolic dysfunction.

Blood Pressure

High blood pressure often travels alongside insulin resistance, obesity, and other metabolic risk factors.

Liver Health

Fat accumulation in the liver can be another manifestation of metabolic dysfunction. Of note, GLP-1 medications are approved for the treatment of fatty liver disease, which is an exciting medical advancement in this disease process!

Muscle Mass and Strength

Muscle plays an important role in glucose regulation, metabolism, mobility, and healthy aging.

This is why Weight Loss NP approaches medical weight loss as metabolic care, not just scale management.

You Can Have Metabolic Risk Before Your BMI Becomes “High Enough”

This may be one of the most important implications of moving beyond BMI.

Some patients have significant metabolic risk at lower body weights.

They may have:

• Prediabetes
• PCOS or PMOS
• Insulin resistance
• High triglycerides
• Fatty liver disease
• Hypertension
• Sleep apnea
• Significant abdominal fat
• Strong family history of diabetes or cardiovascular disease

Yet they may have been told that their weight “isn’t bad enough” to warrant treatment.

A more individualized metabolic approach allows clinicians to intervene earlier rather than waiting for someone’s BMI or lab values to cross an arbitrary threshold.

Does This Mean BMI Is Useless?

No.

BMI remains a useful screening measurement, and many medication and insurance eligibility criteria still rely on it.

But it should be one data point.

A comprehensive assessment may include BMI alongside waist circumference, labs, medical history, medications, symptoms, body composition, family history, hormone health, sleep, nutrition, and physical activity.

The goal is to understand the whole of a person’s health beyond a simple number.

What Does This Mean for GLP-1 Weight Loss Treatment?

Medications such as semaglutide and tirzepatide have also changed the way we think about obesity treatment.

For appropriate patients, GLP-1-based medications can support meaningful improvements in weight, blood sugar regulation, appetite, and cardiometabolic health.

But medication decisions should still be individualized.

At Weight Loss NP, our GLP-1 weight loss program considers the patient’s metabolic health, weight history, medical conditions, symptoms, lifestyle, goals, and long-term maintenance plan.

The goal should not simply be reaching a lower number on the scale, or a lower BMI.

The goal is improving health! Helping you lead a healthier, more vibrant life for years to come.

Metabolic Health and Medical Weight Loss in Denver, Colorado, Utah, and Florida

For patients in Denver, Arvada, and throughout Colorado, as well as Utah and Florida, Weight Loss NP offers a comprehensive medical approach to medical weight loss.

Depending on the patient, that may include:

• GLP-1 medications
• Nutrition support
• Insulin resistance management
• Muscle preservation strategies
• Hormone evaluation and treatment when appropriate
• HRT for women
• TRT for men
• Metabolic lab monitoring
• Long-term weight maintenance planning

We want to understand why weight is changing and what health risks are developing, not simply assign someone a BMI category.

The Bigger Picture

Medicine is gradually moving toward something patients have needed for a long time: a more individualized understanding of obesity and metabolic health. Weight Loss NP has lead the way and is passionate about providing expert personalized care to our clients.

BMI still has value.

But your health is more dynamic than a height-to-weight equation.

If your blood sugar, insulin resistance, abdominal fat, cholesterol, blood pressure, hormones, or weight are changing, those signals deserve attention even when your BMI does not tell the whole story.

That is the direction modern metabolic medicine is moving, and I think it is a better one.

Start your journey to improved metabolic health by scheduling your FREE consultation now!